TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35383975 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33459945 — Safety Biomarker (SAF): Cytochrome c
Study 32125249 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32125249 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33230706 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 35788657 — Surrogate Endpoint (SUR): Serum uric acid
Study 32115267 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 33069784 — Surrogate Endpoint (SUR): Blood pressure
Study 34064968 — Surrogate Endpoint (SUR): Blood pressure
Study 35879524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32810344 — Surrogate Endpoint (SUR): Blood pressure
Study 34111616 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 35266064 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 35266064 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 32302504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35624509 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33077124 — Surrogate Endpoint (SUR): Blood pressure
Study 34298398 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 34298398 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 32502876 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 37150125 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 37150125 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37150125 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 33814437 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 34275797 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34275797 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 34275797 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35031139 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 33547330 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34152632 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34152632 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34152632 — Monitoring Biomarker (MOI): Procalcitonin
Study 35192543 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35192543 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33932814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33932814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34893523 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34893523 — Predictive Biomarker (PRD): GRB7 mRNA
Genes: GRB7
Study 34893523 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35278124 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 35710124 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 34919684 — Surrogate Endpoint (SUR): Blood pressure
Study 34919684 — Surrogate Endpoint (SUR): Serum triglycerides
Study 35265960 — Surrogate Endpoint (SUR): Blood pressure
Study 35306660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33720541 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study 33021196 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34815548 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34815548 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 34815548 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 32249112 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36036648 — Surrogate Endpoint (SUR): Blood pressure
Study 33068157 — Surrogate Endpoint (SUR): Bone mineral density
Study 33369020 — Surrogate Endpoint (SUR): Blood pressure
Study 33369020 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34217789 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 34217789 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33263644 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36102002 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study 32500827 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32500827 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 34752941 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32416376 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32473928 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 32488332 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 33380479 — Surrogate Endpoint (SUR): Blood pressure
Study 33940549 — Surrogate Endpoint (SUR): Blood pressure
Study 33387333 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33387333 — Safety Biomarker (SAF): BDNF
Study 34162719 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35537786 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34475094 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 34475094 — Predictive Biomarker (PRD): CKS2 mRNA
Genes: CKS2
Study 34475094 — Predictive Biomarker (PRD): OAS2 mRNA
Genes: OAS2
Study 34475094 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study 33675755 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 36048348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 36197264 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 36197264 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 34117276 — Surrogate Endpoint (SUR): Blood pressure
Study 32358086 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32272181 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study 32272181 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 32272181 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32272181 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 33709982 — Surrogate Endpoint (SUR): Blood pressure
Study 32951743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36056721 — Surrogate Endpoint (SUR): Serum creatinine
Study 33234670 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33234670 — Surrogate Endpoint (SUR): Blood pressure
Study 33234670 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33234670 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33484897 — Surrogate Endpoint (SUR): Blood pressure
Study 32376326 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 36219198 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 36219198 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 33946212 — Surrogate Endpoint (SUR): Blood pressure
Study 33864068 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 33333147 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33429762 — Surrogate Endpoint (SUR): Serum creatinine
Study 33429762 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 33081606 — Surrogate Endpoint (SUR): Bone mineral density
Study 35778318 — Predictive Biomarker (PRD): MC1R mRNA
Genes: MC1R; MSHR
Study 32609011 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 35239968 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33355217 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33032471 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35589595 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32611648 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32611648 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study 34422262 — Surrogate Endpoint (SUR): Blood pressure
Study 35675902 — Surrogate Endpoint (SUR): Blood pressure
Study 35383339 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 35383339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33655789 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 33143121 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 33049489 — Surrogate Endpoint (SUR): Blood pressure
Study 33049489 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33524191 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 32822614 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35708690 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32951121 — Surrogate Endpoint (SUR): Blood pressure
Study 35428324 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 35223519 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35435981 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study 32404518 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 35459446 — Surrogate Endpoint (SUR): Blood pressure
Study 34959879 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33620131 — Surrogate Endpoint (SUR): Blood pressure
Study 33104756 — Surrogate Endpoint (SUR): Serum creatinine
Study 33121297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33050947 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35631072 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33807284 — Surrogate Endpoint (SUR): Bone mineral density
Study 34358734 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 32755100 — Surrogate Endpoint (SUR): Blood pressure
Study 32739045 — Surrogate Endpoint (SUR): Blood pressure
Study 32730913 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 35313959 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35313959 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 35313959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35313959 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36364884 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33290610 — Predictive Biomarker (PRD): Hormone receptor
Study 33564684 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33564684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35794660 — Surrogate Endpoint (SUR): Blood pressure
Study 34129252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32757879 — Predictive Biomarker (PRD): ELAVL2 mRNA
Genes: ELAVL2; HUB
Study 32927091 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 35782699 — Surrogate Endpoint (SUR): Blood pressure
Study 34429172 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 36107462 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33274381 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 32553077 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 32553077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33822067 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 32873667 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34265044 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34265044 — Surrogate Endpoint (SUR): Blood pressure
Study 33022421 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 33302661 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33400845 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34337913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32119803 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36474395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32463566 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study 32463566 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32463566 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32681239 — Predictive Biomarker (PRD): ROBO2 mRNA
Genes: ROBO2; KIAA1568
Study 32681239 — Predictive Biomarker (PRD): CTNND2 mRNA
Genes: CTNND2; NPRAP
Study 32681239 — Predictive Biomarker (PRD): SGCZ mRNA
Genes: SGCZ
Study 32681239 — Predictive Biomarker (PRD): CNTN5 mRNA
Genes: CNTN5
Study 32681239 — Predictive Biomarker (PRD): BAIAP2 mRNA
Genes: BAIAP2
Study 35101369 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 32648924 — Surrogate Endpoint (SUR): Blood pressure
Study 34224251 — Predictive Biomarker (PRD): Liver iron
Study 32029355 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 36351326 — Safety Biomarker (SAF): BDNF
Study 32792679 — Monitoring Biomarker (MOI): Procalcitonin
Study 32792679 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32792679 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34375387 — Surrogate Endpoint (SUR): Blood pressure
Study 33191846 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 616117430 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 35748715 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 35248121 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35248121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33615722 — Surrogate Endpoint (SUR): Blood pressure
Study 36356514 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 34472754 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 34472754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34472754 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 34472754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34472754 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34472754 — Safety Biomarker (SAF): IL-6 and IL-10
Study 32480076 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 33664161 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 33664161 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 33052760 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35344476 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35344476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33417663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32379280 — Predictive Biomarker (PRD): Microsatellite instability
Study 32379280 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32379280 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34278827 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35932065 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 35932065 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34267689 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 35301577 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 35301577 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 34341423 — Predictive Biomarker (PRD): MYB mRNA
Genes: MYB
Study 34341423 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34341423 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 32660725 — Safety Biomarker (SAF): Hyaluronic acid
Study 33076762 — Surrogate Endpoint (SUR): Blood pressure
Study 32965715 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33206263 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33710154 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 36002594 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 35686365 — Safety Biomarker (SAF): Reactive oxygen species
Study 32091548 — Surrogate Endpoint (SUR): Bone mineral density
Study 32498561 — Surrogate Endpoint (SUR): Blood pressure
Study 33009241 — Surrogate Endpoint (SUR): Blood pressure
Study 33775867 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 33775867 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33109240 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33407276 — Surrogate Endpoint (SUR): Blood pressure
Study 34426442 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34871204 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 33131126 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 35763249 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32267032 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 32267032 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 32267032 — Predictive Biomarker (PRD): SLC9A1 mRNA
Genes: SLC9A1; APNH1; NHE1
Study 32779001 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 32779001 — Surrogate Endpoint (SUR): Blood pressure
Study 35569763 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 33113088 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35564330 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study 34639313 — Predictive Biomarker (PRD): VAPA mRNA
Genes: VAPA; VAP33
Study 34639313 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32456236 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 35672660 — Surrogate Endpoint (SUR): Blood pressure
Study 34292493 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 35302207 — Surrogate Endpoint (SUR): Blood pressure
Study 33580595 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 33580595 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 33580595 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study 32167393 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 32167393 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 32167393 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35064330 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32353342 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32353342 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32353342 — Predictive Biomarker (PRD): Hormone receptor
Study 32661681 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 32661681 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 32661681 — Predictive Biomarker (PRD): NPSR1 mRNA
Genes: NPSR1; GPR154; GPRA; PGR14
Study 32661681 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study 34167597 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34167597 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32017817 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32017817 — Safety Biomarker (SAF): BDNF
Study 35578268 — Predictive Biomarker (PRD): PRKAR1B mRNA
Genes: PRKAR1B
Study 35578268 — Predictive Biomarker (PRD): PDE4C mRNA
Genes: PDE4C; DPDE1
Study 35098782 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35098782 — Safety Biomarker (SAF): IL-6 and IL-10
Study 32732354 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 32732354 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study 32732354 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 32732354 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study 32732354 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A